Global Drug-Eluting Stents Market Size study & Forecast, by Coating (Polymer Based, Polymer Free), By Application (Coronary Artery Disease, Peripheral Artery Disease), By End-User (Hospitals, Ambulatory Surgical Centers, Others) and Regional Analysis, 2023-2030
Global Drug-Eluting Stents Market is valued at approximately USD 7.37 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.6% over the forecast period 2023-2030. Drug-eluting stents are medical devices used in interventional cardiology to treat narrowed or blocked arteries; a condition known as coronary artery disease. They are tiny metal tubes, usually made of stainless steel or cobalt-chromium alloy, that are coated with a special medication designed to prevent the formation of scar tissue inside the artery and keep it open for blood flow. The Drug-Eluting Stents market is expanding because of factors such as increasing prevalence of cardiovascular disease and rise in geriatric population. The development of DES has revolutionized the treatment of coronary artery disease by reducing the risk of re-narrowing the artery, known as restenosis, which was a common problem with bare-metal stents. Its prevalence has progressively increased during the last few decades.
According to the American Heart Association, Cardiovascular disease remains the leading cause of death in the United States, accounting for 928,741 deaths in the year 2020. Furthermore, in 2020 in the United States, coronary heart disease was the leading cause of death around 41.2% attributable to CVD in the United States, followed by stroke at 17.3%, and other cardiovascular diseases at 16.8%. Another important component driving space is rise in geriatric population. As geriatric and obese populations are predisposed to chronic diseases. According to the World Bank Group, the world’s old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. In addition, in May 2022, Biosensors International Group launched BioFreedom Ultra. It is a new polymer and carrier-free drug-coated stent using Biosensors' patented limus medication Biolimus A9. It is a highly lipophilic anti-restenotic medication developed by Biosensors intended for coronary vascular applications. BioFreedom Ultra additionally includes 84m thin Cobalt Chromium (Co/Cr) struts. Also, advancements in the formulation of drug-eluting stents and increasing demand for biodegradable polymer-based drug eluting scaffolds would create a lucrative growth prospectus for the market over the forecast period. However, the high cost of Drug-Eluting Stents stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Drug-Eluting Stents Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players and rising technological advancement in health examination devices. According to Statista, in 2021, the number of cardiovascular surgeries in North America accounts for 202907 Coronary Artery Bypass Graft Procedures, and 258139 Isolated Valve Procedures. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric populations, and active participation of government organizations in the market space.
Major market players included in this report are:
Boston Scientific Corporation,
Medtronic plc
Abbott Laboratories,
Biosensors International Group,
AlviMedica Medical Technologies Inc.,
Amaranth Medical, Inc.,
HangZhou HuaAn Biotechnology Co., Ltd,
XTENT, Inc.,
Cardionovum GmbH,
Kyoto Medical Planning Co., Ltd.
Recent Developments in the Market:
In February 2023, Medtronic plc acquired the CE Mark for the Aurora EV-ICDTM MRI SureScanTM and Epsila EVTM MRI SureScanTM defibrillation leads for the treatment of extremely fast heartbeats that can lead to sudden cardiac arrest. Because its lead (thin wire) is located outside the heart and veins, the Aurora EV-ICD system provides the life-saving benefits of regular ICDs while avoiding certain hazards.
Global Drug-Eluting Stents Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Coating, Application, End-User, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Coating
Polymer Based
Polymer Free
By Application
Coronary Artery Disease
Peripheral Artery Disease
By End-User
Hospitals
Ambulatory Surgical Centers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
According to the American Heart Association, Cardiovascular disease remains the leading cause of death in the United States, accounting for 928,741 deaths in the year 2020. Furthermore, in 2020 in the United States, coronary heart disease was the leading cause of death around 41.2% attributable to CVD in the United States, followed by stroke at 17.3%, and other cardiovascular diseases at 16.8%. Another important component driving space is rise in geriatric population. As geriatric and obese populations are predisposed to chronic diseases. According to the World Bank Group, the world’s old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. In addition, in May 2022, Biosensors International Group launched BioFreedom Ultra. It is a new polymer and carrier-free drug-coated stent using Biosensors' patented limus medication Biolimus A9. It is a highly lipophilic anti-restenotic medication developed by Biosensors intended for coronary vascular applications. BioFreedom Ultra additionally includes 84m thin Cobalt Chromium (Co/Cr) struts. Also, advancements in the formulation of drug-eluting stents and increasing demand for biodegradable polymer-based drug eluting scaffolds would create a lucrative growth prospectus for the market over the forecast period. However, the high cost of Drug-Eluting Stents stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Drug-Eluting Stents Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players and rising technological advancement in health examination devices. According to Statista, in 2021, the number of cardiovascular surgeries in North America accounts for 202907 Coronary Artery Bypass Graft Procedures, and 258139 Isolated Valve Procedures. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric populations, and active participation of government organizations in the market space.
Major market players included in this report are:
Boston Scientific Corporation,
Medtronic plc
Abbott Laboratories,
Biosensors International Group,
AlviMedica Medical Technologies Inc.,
Amaranth Medical, Inc.,
HangZhou HuaAn Biotechnology Co., Ltd,
XTENT, Inc.,
Cardionovum GmbH,
Kyoto Medical Planning Co., Ltd.
Recent Developments in the Market:
In February 2023, Medtronic plc acquired the CE Mark for the Aurora EV-ICDTM MRI SureScanTM and Epsila EVTM MRI SureScanTM defibrillation leads for the treatment of extremely fast heartbeats that can lead to sudden cardiac arrest. Because its lead (thin wire) is located outside the heart and veins, the Aurora EV-ICD system provides the life-saving benefits of regular ICDs while avoiding certain hazards.
Global Drug-Eluting Stents Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Coating, Application, End-User, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Coating
Polymer Based
Polymer Free
By Application
Coronary Artery Disease
Peripheral Artery Disease
By End-User
Hospitals
Ambulatory Surgical Centers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Drug-Eluting Stents Market, by Region, 2020-2030 (USD Billion)
1.2.2. Drug-Eluting Stents Market, by Coating, 2020-2030 (USD Billion)
1.2.3. Drug-Eluting Stents Market, by Application, 2020-2030 (USD Billion)
1.2.4. Drug-Eluting Stents Market, by End-User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL DRUG-ELUTING STENTS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL DRUG-ELUTING STENTS MARKET DYNAMICS
3.1. Drug-Eluting Stents Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of cardiovascular disease
3.1.1.2. Rise in Geriatric Population
3.1.2. Market Challenges
3.1.2.1. High Cost of Drug-Eluting Stents
3.1.3. Market Opportunities
3.1.3.1. Advancements in Formulation of Drug-Eluting Stents
3.1.3.2. Increasing demand for biodegradable polymer-based drug eluting scaffolds
CHAPTER 4. GLOBAL DRUG-ELUTING STENTS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL DRUG-ELUTING STENTS MARKET, BY COATING
5.1. Market Snapshot
5.2. Global Drug-Eluting Stents Market by Coating, Performance - Potential Analysis
5.3. Global Drug-Eluting Stents Market Estimates & Forecasts by Coating 2020-2030 (USD Billion)
5.4. Drug-Eluting Stents Market, Sub Segment Analysis
5.4.1. Polymer Based
5.4.2. Polymer Free
CHAPTER 6. GLOBAL DRUG-ELUTING STENTS MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Drug-Eluting Stents Market by Application, Performance - Potential Analysis
6.3. Global Drug-Eluting Stents Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Drug-Eluting Stents Market, Sub Segment Analysis
6.4.1. Coronary Artery Disease
6.4.2. Peripheral Artery Disease
CHAPTER 7. GLOBAL DRUG-ELUTING STENTS MARKET, BY END-USER
7.1. Market Snapshot
7.2. Global Drug-Eluting Stents Market by End-User, Performance - Potential Analysis
7.3. Global Drug-Eluting Stents Market Estimates & Forecasts by End-User 2020-2030 (USD Billion)
7.4. Drug-Eluting Stents Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Ambulatory Surgical Centres
7.4.3. Others
CHAPTER 8. GLOBAL DRUG-ELUTING STENTS MARKET, REGIONAL ANALYSIS
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Drug-Eluting Stents Market, Regional Market Snapshot
8.4. North America Drug-Eluting Stents Market
8.4.1. U.S. Drug-Eluting Stents Market
8.4.1.1. Coating breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. End-User breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Drug-Eluting Stents Market
8.5. Europe Drug-Eluting Stents Market Snapshot
8.5.1. U.K. Drug-Eluting Stents Market
8.5.2. Germany Drug-Eluting Stents Market
8.5.3. France Drug-Eluting Stents Market
8.5.4. Spain Drug-Eluting Stents Market
8.5.5. Italy Drug-Eluting Stents Market
8.5.6. Rest of Europe Drug-Eluting Stents Market
8.6. Asia-Pacific Drug-Eluting Stents Market Snapshot
8.6.1. China Drug-Eluting Stents Market
8.6.2. India Drug-Eluting Stents Market
8.6.3. Japan Drug-Eluting Stents Market
8.6.4. Australia Drug-Eluting Stents Market
8.6.5. South Korea Drug-Eluting Stents Market
8.6.6. Rest of Asia Pacific Drug-Eluting Stents Market
8.7. Latin America Drug-Eluting Stents Market Snapshot
8.7.1. Brazil Drug-Eluting Stents Market
8.7.2. Mexico Drug-Eluting Stents Market
8.8. Middle East & Africa Drug-Eluting Stents Market
8.8.1. Saudi Arabia Drug-Eluting Stents Market
8.8.2. South Africa Drug-Eluting Stents Market
8.8.3. Rest of Middle East & Africa Drug-Eluting Stents Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Company
9.1.2. Company
9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Boston Scientific Corporation
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Medtronic plc
9.3.3. Abbott Laboratories
9.3.4. Biosensors International Group
9.3.5. AlviMedica Medical Technologies Inc.
9.3.6. Amaranth Medical, Inc.
9.3.7. HangZhou HuaAn Biotechnology Co., Ltd
9.3.8. XTENT, Inc.
9.3.9. Cardionovum GmbH
9.3.10. Kyoto Medical Planning Co., Ltd.
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Drug-Eluting Stents Market, by Region, 2020-2030 (USD Billion)
1.2.2. Drug-Eluting Stents Market, by Coating, 2020-2030 (USD Billion)
1.2.3. Drug-Eluting Stents Market, by Application, 2020-2030 (USD Billion)
1.2.4. Drug-Eluting Stents Market, by End-User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL DRUG-ELUTING STENTS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL DRUG-ELUTING STENTS MARKET DYNAMICS
3.1. Drug-Eluting Stents Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of cardiovascular disease
3.1.1.2. Rise in Geriatric Population
3.1.2. Market Challenges
3.1.2.1. High Cost of Drug-Eluting Stents
3.1.3. Market Opportunities
3.1.3.1. Advancements in Formulation of Drug-Eluting Stents
3.1.3.2. Increasing demand for biodegradable polymer-based drug eluting scaffolds
CHAPTER 4. GLOBAL DRUG-ELUTING STENTS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL DRUG-ELUTING STENTS MARKET, BY COATING
5.1. Market Snapshot
5.2. Global Drug-Eluting Stents Market by Coating, Performance - Potential Analysis
5.3. Global Drug-Eluting Stents Market Estimates & Forecasts by Coating 2020-2030 (USD Billion)
5.4. Drug-Eluting Stents Market, Sub Segment Analysis
5.4.1. Polymer Based
5.4.2. Polymer Free
CHAPTER 6. GLOBAL DRUG-ELUTING STENTS MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Drug-Eluting Stents Market by Application, Performance - Potential Analysis
6.3. Global Drug-Eluting Stents Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Drug-Eluting Stents Market, Sub Segment Analysis
6.4.1. Coronary Artery Disease
6.4.2. Peripheral Artery Disease
CHAPTER 7. GLOBAL DRUG-ELUTING STENTS MARKET, BY END-USER
7.1. Market Snapshot
7.2. Global Drug-Eluting Stents Market by End-User, Performance - Potential Analysis
7.3. Global Drug-Eluting Stents Market Estimates & Forecasts by End-User 2020-2030 (USD Billion)
7.4. Drug-Eluting Stents Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Ambulatory Surgical Centres
7.4.3. Others
CHAPTER 8. GLOBAL DRUG-ELUTING STENTS MARKET, REGIONAL ANALYSIS
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Drug-Eluting Stents Market, Regional Market Snapshot
8.4. North America Drug-Eluting Stents Market
8.4.1. U.S. Drug-Eluting Stents Market
8.4.1.1. Coating breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. End-User breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Drug-Eluting Stents Market
8.5. Europe Drug-Eluting Stents Market Snapshot
8.5.1. U.K. Drug-Eluting Stents Market
8.5.2. Germany Drug-Eluting Stents Market
8.5.3. France Drug-Eluting Stents Market
8.5.4. Spain Drug-Eluting Stents Market
8.5.5. Italy Drug-Eluting Stents Market
8.5.6. Rest of Europe Drug-Eluting Stents Market
8.6. Asia-Pacific Drug-Eluting Stents Market Snapshot
8.6.1. China Drug-Eluting Stents Market
8.6.2. India Drug-Eluting Stents Market
8.6.3. Japan Drug-Eluting Stents Market
8.6.4. Australia Drug-Eluting Stents Market
8.6.5. South Korea Drug-Eluting Stents Market
8.6.6. Rest of Asia Pacific Drug-Eluting Stents Market
8.7. Latin America Drug-Eluting Stents Market Snapshot
8.7.1. Brazil Drug-Eluting Stents Market
8.7.2. Mexico Drug-Eluting Stents Market
8.8. Middle East & Africa Drug-Eluting Stents Market
8.8.1. Saudi Arabia Drug-Eluting Stents Market
8.8.2. South Africa Drug-Eluting Stents Market
8.8.3. Rest of Middle East & Africa Drug-Eluting Stents Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Company
9.1.2. Company
9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Boston Scientific Corporation
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Medtronic plc
9.3.3. Abbott Laboratories
9.3.4. Biosensors International Group
9.3.5. AlviMedica Medical Technologies Inc.
9.3.6. Amaranth Medical, Inc.
9.3.7. HangZhou HuaAn Biotechnology Co., Ltd
9.3.8. XTENT, Inc.
9.3.9. Cardionovum GmbH
9.3.10. Kyoto Medical Planning Co., Ltd.
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Drug-Eluting Stents Market, report scope
TABLE 2. Global Drug-Eluting Stents Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Drug-Eluting Stents Market estimates & forecasts by Coating 2020-2030 (USD Billion)
TABLE 4. Global Drug-Eluting Stents Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Drug-Eluting Stents Market estimates & forecasts by End-User 2020-2030 (USD Billion)
TABLE 6. Global Drug-Eluting Stents Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Drug-Eluting Stents Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Drug-Eluting Stents Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Drug-Eluting Stents Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Drug-Eluting Stents Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Drug-Eluting Stents Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Drug-Eluting Stents Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Drug-Eluting Stents Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Drug-Eluting Stents Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Drug-Eluting Stents Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Drug-Eluting Stents Market
TABLE 71. List of primary sources, used in the study of global Drug-Eluting Stents Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Drug-Eluting Stents Market, report scope
TABLE 2. Global Drug-Eluting Stents Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Drug-Eluting Stents Market estimates & forecasts by Coating 2020-2030 (USD Billion)
TABLE 4. Global Drug-Eluting Stents Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Drug-Eluting Stents Market estimates & forecasts by End-User 2020-2030 (USD Billion)
TABLE 6. Global Drug-Eluting Stents Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Drug-Eluting Stents Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Drug-Eluting Stents Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Drug-Eluting Stents Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Drug-Eluting Stents Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Drug-Eluting Stents Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Drug-Eluting Stents Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Drug-Eluting Stents Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Drug-Eluting Stents Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Drug-Eluting Stents Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Drug-Eluting Stents Market
TABLE 71. List of primary sources, used in the study of global Drug-Eluting Stents Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Drug-Eluting Stents Market, research methodology
FIG 2. Global Drug-Eluting Stents Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Drug-Eluting Stents Market, key trends 2022
FIG 5. Global Drug-Eluting Stents Market, growth prospects 2023-2030
FIG 6. Global Drug-Eluting Stents Market, porters 5 force model
FIG 7. Global Drug-Eluting Stents Market, pest analysis
FIG 8. Global Drug-Eluting Stents Market, value chain analysis
FIG 9. Global Drug-Eluting Stents Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Drug-Eluting Stents Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Drug-Eluting Stents Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Drug-Eluting Stents Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Drug-Eluting Stents Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Drug-Eluting Stents Market, regional snapshot 2020 & 2030
FIG 15. North America Drug-Eluting Stents Market 2020 & 2030 (USD Billion)
FIG 16. Europe Drug-Eluting Stents Market 2020 & 2030 (USD Billion)
FIG 17. Asia Pacific Drug-Eluting Stents Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Drug-Eluting Stents Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Drug-Eluting Stents Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Drug-Eluting Stents Market, research methodology
FIG 2. Global Drug-Eluting Stents Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Drug-Eluting Stents Market, key trends 2022
FIG 5. Global Drug-Eluting Stents Market, growth prospects 2023-2030
FIG 6. Global Drug-Eluting Stents Market, porters 5 force model
FIG 7. Global Drug-Eluting Stents Market, pest analysis
FIG 8. Global Drug-Eluting Stents Market, value chain analysis
FIG 9. Global Drug-Eluting Stents Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Drug-Eluting Stents Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Drug-Eluting Stents Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Drug-Eluting Stents Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Drug-Eluting Stents Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Drug-Eluting Stents Market, regional snapshot 2020 & 2030
FIG 15. North America Drug-Eluting Stents Market 2020 & 2030 (USD Billion)
FIG 16. Europe Drug-Eluting Stents Market 2020 & 2030 (USD Billion)
FIG 17. Asia Pacific Drug-Eluting Stents Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Drug-Eluting Stents Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Drug-Eluting Stents Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
